These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 34499010)
1. A novel long non-coding RNA-based prognostic signature for renal cell carcinoma patients with stage IV and histological grade G4. Li N; Zhang H; Hu K; Chu J Bioengineered; 2021 Dec; 12(1):6275-6285. PubMed ID: 34499010 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma. Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382 [TBL] [Abstract][Full Text] [Related]
3. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
4. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma. Ma W; Zhong M; Liu X Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862 [TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma. Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187 [TBL] [Abstract][Full Text] [Related]
6. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Nine-Redox-Related Long Noncoding RNA Signature in Renal Clear Cell Carcinoma. Qi-Dong X; Yang X; Lu JL; Liu CQ; Sun JX; Li C; Wang SG Oxid Med Cell Longev; 2020; 2020():6634247. PubMed ID: 33425212 [TBL] [Abstract][Full Text] [Related]
8. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma. Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371 [TBL] [Abstract][Full Text] [Related]
9. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
10. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma. Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816 [TBL] [Abstract][Full Text] [Related]
11. A Novel Tumor Mutation Burden Related lncRNA Signature Identified Prognosis and Tumor Immune Microenvironment Features in Clear Cell Renal Cell Carcinoma. Lin L; Wu XH; Zhu JM; Chen SH; Chen YH; Lin F; Xue XY; Wei Y; Xu N; Zheng QS; Sun XL Comb Chem High Throughput Screen; 2023; 26(8):1503-1518. PubMed ID: 36165528 [TBL] [Abstract][Full Text] [Related]
12. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer. Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405 [TBL] [Abstract][Full Text] [Related]
13. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
14. High expression of long non-coding RNA ATB is associated with poor prognosis in patients with renal cell carcinoma. Qi JJ; Liu YX; Lin L Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2835-2839. PubMed ID: 28682434 [TBL] [Abstract][Full Text] [Related]
15. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma. Liu Y; Gou X; Wei Z; Yu H; Zhou X; Li X Aging (Albany NY); 2020 Jul; 12(15):15359-15373. PubMed ID: 32716909 [TBL] [Abstract][Full Text] [Related]
16. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma. Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
19. A Risk Signature with Autophagy-Related Long Noncoding RNAs for Predicting the Prognosis of Clear Cell Renal Cell Carcinoma: Based on the TCGA Database and Bioinformatics. Xuan Y; Chen W; Liu K; Gao Y; Zuo S; Wang B; Ma X; Zhang X Dis Markers; 2021; 2021():8849977. PubMed ID: 34040677 [TBL] [Abstract][Full Text] [Related]
20. Construction and validation of an autophagy-related long non-coding RNA signature to predict the prognosis of kidney renal papillary cell carcinoma. Kang Z; Yang J J Investig Med; 2022 Oct; 70(7):1536-1544. PubMed ID: 35725019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]